NCT01783626View on ClinicalTrials.gov

Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +)

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
End Stage Renal Disease (ESRD)
Interventions
DEVICE

Evodial

DEVICE

Evodial+ Condition B1

DEVICE

Evodial+ Condition B2

DEVICE

Evodial+ Condition C

Trial Locations (1)

50102

Hôpital Louis-Pasteur (Cherbourg-Octeville), Cherbourg-Octeville

All Listed Sponsors
collaborator

Gambro Lundia AB

INDUSTRY

collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Vantive Health LLC

INDUSTRY

NCT01783626 - Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +) | Biotech Hunter | Biotech Hunter